IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Navidea Biopharmaceuticals I (NAVBQ)

CUSIP: 63937X202 | NYSE | 82 institutional holders

Quarters

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2025

Front Row Advisors LLC280
0.0% of portfolio›$0
Ancora Advisors LLCA100
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Front Row Advisors LLC
280$00.0%GrowthVery LowTiburon, CA2026-02-12
Ancora Advisors LLCActivist
100$00.0%ValueMediumCleveland, OH2026-02-17